The distribution of an epitope of the transferrin receptor in the human uterine cervical epithelium has been investigated. Immunohistochemical staining, both immunofluorescent and immunoperoxidase, was performed on biopsy specimens and cytological samples from normal, dysplastic, and neoplastic cervical epithelia using the monoclonal OKT9 antibody. The results of staining 145 cervical biopsy specimens with OKT9 showed widespread staining in all malignant epithelia and most severely dysplastic epithelia. No such staining was seen in either normal epithelia or in mildly dysplastic epithelia apart from the staining of the basal cell layer in some normal epithelia. The incidence of staining in the 50 cervical cytocentrifuge preparations was not as high as that in the 145 tissue sections.
The monoclonal antibody OKT9, raised against human leukaemia cells, recognises an epitope of the transferrin receptor.' This receptor is thought to have an essential role in the transport of iron across the cell membrane and has been detected on cells which have a large iron requirement such as reticulocytes and placental syncytiotrophoblast.23 In addition to this the receptor has a widespread distribution on transformed human cell lines4 and an association with cell proliferation and activation.5' The transferrin receptor has been found on breast cancer cells 9 and antitransferrin receptor antibody inhibits human tumour cell growth in mice.'0 This work on proliferating and malignant cells encouraged us to investigate the distribution of the transferrin receptor in the human uterine cervix. In this study biopsy specimens and cytological samples from normal, dysplastic, and malignant epithelia were examined using the OKT9 antibody in immunofluorescence and immunoperoxidase techniques. 
CYTOCENTRIFUGE CELL PREPARATIONS
Cervical scrapes were taken at the colposcopy clinic, and after preparing a smear for cytological evaluation the cells were centrifuged as previously described.'6 The slides thus prepared were stored at -80°C before immunostaining. The technique used therefore bears similarities to work done on cervical cell imprints," rather than to work done on unfixed cervical cells in suspension.'213 IMMUNOFLUORESCENCE Immunofluorescence was performed on frozen sections of fresh cervical biopsies and normal placenta. Sections of tissue were incubated for 60 min with OKT9 or control antibody (OKT4, OKT8) diluted 1/20 in phosphate buffered saline (PBS). The sections were washed three times for 10 min each in PBS and incubated for 30 min in goat antimouse fluorescein isothiocyanate conjugate at a dilution of 1/50 in PBS. The sections were then washed three times for 10 min each in PBS, mounted in glycerol! PBS, and examined using a Reichert-Jung Polyvar microscope with a 200W mercury vapour lamp, a blue BP 455-490 incident light exciter filter, a DS 500 dichroic mirror, and a blue LP 515 barrier filter. Adjacent sections were stained with haematoxylin and eosin for routine histological diagnosis.
IMMUNOPEROXIDASE
Cell preparations were examined using an indirect immunoperoxidase method. The diagnosis of cervical cytology is based largely on nuclear detail, and immunoperoxidase is more suitable than immunofluorescence for showing the cell nucleus in these preparations.
The prepared slides were incubated for 60 min with OKT9 or control antibody diluted 1/20 in Tris buffered saline (TBS) (prepared by diluting 0 5 M Tris/HCl buffer (pH 7.6) 1/10 in saline). The preparations were washed three times for 10 min each in TBS and incubated for 30 min in goat antimouse peroxidase conjugate at a dilution of 1/50 in TBS. The slides were then washed three times for 10 min each in TBS and reacted for 5 min with diaminobenzidine tetrahydrochloride at 500 ug/ml in 0-2 Trisl HCl buffer (pH 7.6) containing 0 01% (v/v) hydrogen peroxide (H202). The preparations were washed in tap water for 5 min, stained with haematoxylin, dehydrated in alcohol, cleared in xylene, and mounted in DPX. Endogenous peroxidase is not present in the cells of the ectocervix and therefore did not have to be blocked. Sections of normal human placenta were also examined as controls using this technique.
Lloyd, O'Dowd, Driver, Tee Results PLACENTAL TISSUE By using both the immunofluorescence and the immunoperoxidase techniques the syncytiotrophoblast was positively labelled with OKT9. The central core of the cytotrophoblast did not stain. This is in agreement with the known distribution of transferrin receptors in the trophoblast.2 Neither OKT4 nor OKT8 labelled the sections.
CERVICAL BIOPSIES OKT9 antibody was found, using the immunofluorescence technique, on cells from dysplastic epithelia, carcinoma in situ, and invasive carcinoma. The positive staining reaction was seen throughout the thickness of the epithelium and was located both on the cell membrane and in the cytoplasm (Fig. 1) . The intensity of fluorescence was not constant and varied not only between sections from different biopsies but also within each section of epithelium.
Little or no staining occurred in the cells from normal epithelia. The only staining seen was localised in the basal cell layers of the epithelium and in areas of immature squamous metaplasia. This staining was of low intensity but was uniformly distributed throughout the basal cell layers.
The results of immunofluorescence labelling of 145 cervical biopsies are summarised in Table 1 . All the tumours and most of the severe dysplasias examined showed widespread positive staining with OKT9. Widespread staining was seen in about half of the moderate dysplasia (20/38) and was absent from normal epithelia. About one third of the normal epithelia (15/42) was positively stained in the basal cell layers only. Comparison of the patterns of staining seen in the three categories of dysplasia suggests that there is a positive correlation between the severity of dysplasia and the incidence of widespread positivity.
CYTOCENTRIFUGE CELL PREPARATIONS
The OKT9 antibody was located using the immunoperoxidase technique on malignant and dyskaryotic cells (Fig. 2) The widespread distribution of the transferrin receptors in both dysplastic and malignant cervical epithelia suggests that the OKT9 antibody is not a specific marker for malignancy. The antibody does distinguish, however, between normal cells above the basal layer and severely dysplastic and malignant cells, and it may therefore be possible to use OKT9 for screening cervical smears. The reduced staining seen in the cytocentrifuge preparations, however, sheds some doubt on such screening unless further work on cytological preparations produces staining comparable to that seen in the histological preparations. Screening techniques have been applied to cervical smears,'5 but a consistent cell marker has yet to be found. '6 The appearance of the transferrin receptor in certain dysplasias may be a reflection of an aggressive potential of cells and may signify a role for this marker in the prediction of malignancy. Twenty five patients were followed by colposcopy over a period of up to nine months to study the incidence of the transferrin receptor. Since the histopathology of the cervix varies gradually the duration of the study proved to be too short for any predictive role for the antibody to be determined. It will be necessary to study patients over several years if any such role for OKT9 is to be adequately investigated.
In this laboratory various antibodies (to afetoprotein, human chorionic gonadotrophin, HLA ABC, carcinoembryonic antigen, Ca antigen, and transferrin receptor) have been applied to cervical tissue. Of these, only OKT9 appears to distinguish between normal and abnormal epithelial cells. This work was supported by the Cancer Research Campaign. We thank Professor W Page Faulk and Dr M Levine for their assistance and advice. We are
